|
advertisement
Symbyax
| Generic Name: | olanzapine and fluoxetine HCl |
| Company: | Eli Lilly and Company |
| Web Site: | www.symbyax.com/index.jsp |
| Country: | USA |
| |
 |
| Description: | Symbyax (olanzapine and fluoxetine HCl capsules) combines an atypical antipsychotic and a selective serotonin reuptake inhibitor, olanzapine (the active ingredient in Zyprexa, and Zyprexa Zydis) and fluoxetine hydrochloride (the active ingredient in Prozac, Prozac Weekly, and Sarafem). |
| |
| Indications: | Symbyax combines olanzapine, an atypical antipsychotic and fluoxetine, a selective serotonin reuptake inhibitor, indicated for acute treatment of:
1. Depressive Episodes Associated with Bipolar I Disorder in adults
2. Treatment Resistant Depression (Major Depressive Disorder in adults who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode)
Revised April 2009 |
| |
|
|
|
|
advertisement
|
|
 |
